UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Yuhan licenses out gastrointestinal treatment to US partner
by Lee Han-soo
2020-08-20 16:58
Regulator OKs P2 trial of Covid-19 plasma therapy
by Lee Han-soo
2020-08-20 14:55
KAIST develops model predicting number of imported Covid-19 cases
by Lee Han-soo
2020-08-19 16:13
Bridge Bio shares plummet on possible cancellation of ₩1.5-trillion deal
by Lee Han-soo
2020-08-19 13:07
Korea, Belgium researchers find new mechanism in treating colon cancer
by Lee Han-soo
2020-08-18 17:20
라인
LG Chem licenses in NASH treatment candidate from China
by Lee Han-soo
2020-08-18 15:18
Medytox shares resurge as court allows sales resumption of Meditoxin
by Lee Han-soo
2020-08-18 15:18
GC Labcell confirms efficacy of NK cell therapy in treating Covid-19
by Lee Han-soo
2020-08-18 15:10
[From the scene] Doctors took to streets to protest increase of medical students
by Lee Han-soo
2020-08-14 17:54
SK Bioscience inks CDMO deal with Novavax for Covid-19 vaccine
by Lee Han-soo
2020-08-14 15:36
라인
Celltrion to start P1 trial of Prolia biosimilar
by Lee Han-soo
2020-08-14 15:32
Covid-19 makes Vivozon halt P3 trial of nonnarcotic analgesics in US
by Lee Han-soo
2020-08-13 17:27
KASL holds world’s 1st int’l conference on liver online
by Lee Han-soo
2020-08-13 16:34
Celltrion Healthcare posts record-breaking Q2 profit
by Lee Han-soo
2020-08-13 16:34
Severance finds biomarker for predicting organ damage in ANCA-related vasculitis patients
by Lee Han-soo
2020-08-13 11:13
라인
Takeda expects more effective IBD treatment with Kynteles' expanded reimbursement
by Lee Han-soo
2020-08-12 17:45
Celltrion launches 2 Covid-19 diagnostic kits in US
by Lee Han-soo
2020-08-12 14:49
Roche’s Tecentriq-Avastin combo wins nod to treat hepatocellular carcinoma
by Lee Han-soo
2020-08-12 14:35
Petitioner demands insurance benefit for breast cancer drug Kadcyla
by Kim Yun-mi
2020-08-11 17:49
Daewoong to conduct P1 trial of Covid-19 treatment in India
by Lee Han-soo
2020-08-11 17:48
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top